Fairmount Funds Management LLC - 31 Dec 2025 SCHEDULE 13G/A Report for Inhibikase Therapeutics, Inc. Common Stock, par value $0.001 per share (IKT)

Filing Manager
Fairmount Funds Management LLC
Reporting Manager
Fairmount Funds Management LLC
Security
Inhibikase Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
IKT
Shares outstanding
125,869,707 shares
Disclosed Ownership
12,461,101 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:30:15 UTC
Date of event
31 Dec 2025
Previous filing
14 Feb 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Fairmount Funds Management LLC 9.9% 12,461,101 0 12,461,101 /s/ Peter Harwin Peter Harwin, Managing Member
Fairmount Healthcare Fund II L.P. 9.9% 12,461,101 0 12,461,101 /s/ Peter Harwin Peter Harwin, Member
Peter Harwin 9.9% 12,461,101 0 12,461,101 /s/ Peter Harwin Peter Harwin
Tomas Kiselak 9.9% 12,461,101 0 12,461,101 /s/ Tomas Kiselak Tomas Kiselak